Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Prevention of Postoperative Delirium in Elderly Fracture Patients
NCT04335968Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2021
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in postoperative delirium (POD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2021; status: completed.
02
Drugs
melatonin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04335968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335968.